Core Insights - SOHM, Inc. has received a Notice of Allowance/Approval from the South Korea Patent Office for its innovative gene-editing technology [1] - The patent application is titled "CAS9 Retroviral Integrase and CAS9 Recombinase Systems for Targeted Incorporation of a DNA Sequence into a Genome of a Cell or Organism" [1] - This patent enhances SOHM's global intellectual property portfolio related to the ABBIE gene-editing platform, which integrates dCas9 with retroviral integrases [1]